Rp Management, LLC

About

Royalty Pharma Royalty Pharma Open Search Open Navigation Search Search Close Search Panel Funding the next wave of biopharma innovation Investors Investor Day 2025 Press release Presentation Transcript Deloitte Market Study: Role of Royalties in Funding Biopharma Innovation Royalty Pharma Culture Royalty Pharma Partner Testimonial Royalty Pharma Partner Testimonial (Extended Version) Play Video Watch Deloitte Report on the Biopharma Royalty Market Deloitte’s report, titled Role of Royalties in Funding Biopharma Innovation, is the first of its kind and offers a comprehensive analysis of the current dynamics, growth drivers and outlook for biopharma royalties. Deloitte Market Study: Role of Royalties in Funding Biopharma Innovation Our firm We operate at the intersection of science, medicine and investing We are the world’s largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences. Learn more # 1 Buyer of biopharma royalties >$ 25 bn Capital deployed since founding > 80 Royalty acquisitions since founding Partners Partner with us We are the leading partner funding innovation in life sciences with more than 60% global market share. Our unique capabilities to provide tailored funding solutions and customize win-win partnerships have positioned us as the partner of choice in the biopharma ecosystem. Play Video Who we partner with Our funding solutions Hear from our partners Learn more about Royalty Pharma Play Video Stock information RPRX ${

Key Contact